All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-EPCAM DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-1080-YY | 4A7 | Mouse | IgG1 | |||
DMAb-0250-FY | 323/A3 | Mouse | Human | IgG1, κ | MCF-7 human breast cancer cells | |
DMAb-0251-FY | 60N5D8 | Mouse | Human | IgG2b, κ | Within the range of amino acids 289-335 were used as the immunogen for the EpCAM antibody | |
DMAb-0252-FY | 7B5C10 | Mouse | Human | IgG1 | Purified recombinant fragment of human EPCAM expressed in E.coli | |
DMAb-0253-FY | ABM4D85 | Mouse | Human | IgG2a, κ | ||
DMAb-0254-FY | AUA1 | Mouse | Human | IgG1 | LoVo cell line preparation | |
DMAb-0255-FY | B1368M | Mouse | IgG2b | Recombinant fusion of EpCAM peptide and human thioredoxin | ||
DMAb-0256-FY | Ber-EP4 | Mouse | Human | IgG1 | BALB/C mice were immunized with human breast carcinoma cell line, MCF-7 | |
DMAb-0257-FY | EGP40/1110 | Mouse | IgG2b, κ | A recombinant human EpCAM fragment from the cytoplasmic domain | ||
DMAb-0258-FY | EGP40/1372 | Mouse | Human | IgG | A recombinant human EpCAM fragment from the extracellular domain | |
DMAb-0259-FY | EGP40/1373 | Mouse | Human | IgG2b | Recombinant human EpCAM protein fragment from the extracellular domain | |
DMAb-0260-FY | EGP40/1555R | Rabbit | Human | IgG, κ | A synthetic peptide from the N-terminus of human TACSTD1 protein | |
DMAb-0261-FY | EGP40/1798 | Mouse | Human | IgG2b, κ | Recombinant human EpCAM protein fragment from the extracellular domain | |
DMAb-0262-FY | EGP40/837 | Mouse | Human | IgG1, κ | Recombinant human TACSTD1 protein | |
DMAb-0263-FY | Epcam/1158 | Mouse | IgG1 | It is expressed on baso-lateral cell surface in most simple epithelia and a vast majority of carcinomas | ||
DMAb-0264-FY | ESA214 | Mouse | Human | IgG1 | Small cell lung carcinoma. Remarks: Molecular weight of antigen: 40 kDa | |
DMAb-0265-FY | G8.8 | Rat | Mouse | IgG2a | Glycoconjugates from Balb/C mouse derived medullary thymic epithelial cells | |
DMAb-0266-FY | HEA125 | Mouse | Human | IgG1 | Living human colon carcinoma cell line HT-29 | |
DMAb-0267-FY | MOC-31 | Mouse | Human | IgG1 | ||
DMAb-0268-FY | PAN-EpCAM Cocktail | Mouse | Human | IgG1, κ | Recombinant human Ep-CAM protein | |
DMAb-0269-FY | VU-1D9 | Mouse | Human | IgG1 | ||
DMAb-0775-CQ | GZ-20 | Mouse | Rat | IgG1 | ||
DMAb-0776-CQ | MOC-181 | Mouse | Human | IgG2a | ||
DMAb-0777-CQ | HEA-125 | Mouse | Human | IgG1 | ||
DMAb-0778-CQ | B8-4 | Mouse | Human | IgG1, κ | Recombinant human CD326 (EpCAM), Fc fusion protein | |
DMAb-0265-FY | G8.8 | Rat | Mouse | IgG2a, κ | ||
DMAb-0266-FY | HEA125 | Mouse | IgG1 |
There are currently no customer reviews or questions for Anti-EPCAM DNA-encoded mAb (DMAb), pVAX1 (DMAb-0200-CN). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION